SCHEMBL657595

SCHEMBL657595

[CH]=CC=CC#C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5100810 0.69
SCHEMBL3538842 0.67
SCHEMBL3538841 0.67
SCHEMBL13784614 0.67
SCHEMBL22070187 0.67
Ethyne SCHEMBL28975706 0.65
SCHEMBL187821 0.63
SCHEMBL187820 0.63
SCHEMBL3500074 0.59
SCHEMBL2161868 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110621654-B TRPV1 modulator compounds 安塔尔遗传学公司 2022-11-01 CN disclosed
EP-3621950-B1 TRPV1 MODULATOR COMPOUNDS ANTALGENICS S L (ES) 2021-12-15 EP disclosed
US-20210188758-A1 PHENOXY ACETIC ACIDS AND PHENYL PROPIONIC ACIDS AS PPAR DELTA AGONISTS VTVX HOLDINGS II LLC 2021-06-24 US disclosed
US-10947180-B2 Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists VTV THERAPEUTICS LLC (US) 2021-03-16 US disclosed
US-20200215073-A1 PHENOXY ACETIC ACIDS AND PHENYL PROPIONIC ACIDS AS PPAR DELTA AGONISTS HIGH POINT PHARMACEUTICALS, LLC 2020-07-09 US disclosed
US-20200199063-A1 TRPV1 Modulator Compounds ANTALGENICS, S.L. (ES) 2020-06-25 US disclosed
EP-3621950-A1 TRPV1 MODULATOR COMPOUNDS Antalgenics, S.L. (ES) 2020-03-18 EP disclosed
CN-110621654-A TRPV1 modulator compounds 安塔尔遗传学公司 2019-12-27 CN disclosed
US-10471066-B2 Phenoxy acetic acids and phenyl propionic acids as PPAR delta agonists VTV THERAPEUTICS LLC (US) 2019-11-12 US disclosed
WO-2018206742-A1 TRPV1 MODULATOR COMPOUNDS ANTALGENICS, S.L. (ES) 2018-11-15 WO disclosed
US-6869967-B2 Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives NOVO NORDISK A/S (DK) 2005-03-22 US disclosed
US-20050054624-A1 Modified, hydroxy-substituted aromatic structures having cytoprotective activity WASHINGTON UNIVERSITY (US) 2005-03-10 US disclosed
US-6844456-B2 Modified, hydroxy-substituted aromatic structures having cytoprotective activity WASHINGTON UNIVERSITY (US) 2005-01-18 US disclosed
US-20040143006-A1 Novel compounds, their preparation and use HIGH POINT PHARMACEUTICALS, LLC 2004-07-22 US disclosed
EP-1330467-A2 MODIFIED, HYDROXY-SUBSTITUTED AROMATIC STRUCTURES HAVING CYTOPROTECTIVE ACTIVITY WASHINGTON UNIVERSITY (US) 2003-07-30 EP disclosed
US-20030139473-A1 Novel compounds, their preparation and use VTVX HOLDINGS II LLC 2003-07-24 US disclosed
US-20020103178-A1 Modified, hydroxy-substituted aromatic structures having cytoprotective activity WASHINGTON UNIVERSITY 2002-08-01 US disclosed
WO-2002036605-A2 ESTRONE-DERIVATIVES HAVING CYTOPROTECTIVE ACTIVITY WASHINGTON UNIVERSITY (US) 2002-05-10 WO disclosed
EP-0510947-A1 N-Hydroxy (thio)ureas as 5-lipoxygenase inhibitors ELI LILLY AND COMPANY (US) 1992-10-28 EP disclosed
US-5130485-A For treatment of asthma, arthritis, allergy, inflammatory bowel disease, psoriasis, respiratory system disorders and antiischemic agents ELI LILLY AND COMPANY (US) 1992-07-14 US disclosed